相关实验视频
Updated: Jul 17, 2025

04:20
Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer
Published on: February 9, 2024
967
TRIM32通过增强FBP2无化和降解来促进口腔状细胞癌的进展
Xiao Yang1, Haifeng Ma2, Min Zhang2
1Department of Stomatology, Affiliated Hospital of Jining Medical University, No. 89, Guhuai Road, Jining, 272000, Shandong, China; Postdoctoral Mobile Station of Shandong University of Traditional Chinese Medicine, No. 4655, Daxue Road, Changqing District, Jinan, 250399, Shandong, China.
Biochemical and biophysical research communications
|August 28, 2023
概括
三方基因32 (TRIM32) 通过增强糖解促进口腔状细胞癌 (OSCC) 的生长和转移. 抑制TRIM32可能为OSCC患者提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 异常表达TRIM32 (一种E3泛素酶) 与各种癌症有关.
- 在口腔状细胞癌 (OSCC) 中TRIM32的特定作用尚未完全理解.
研究的目的:
- 研究TRIM32表达及其在OSCC中的功能意义.
- 阐明TRIM32在OSCC中的作用的基础分子机制.
主要方法:
- 对OSCC组织中TRIM32表达的分析.
- 在体外细胞培养实验中,涉及TRIM32敲击的实验.
- 在体内异种移植瘤模型.
- 质谱和共免疫沉以确定蛋白质相互作用.
- 救援测定验证分子路径.
主要成果:
- 在OSCC组织中,TRIM32表达升高,与高级临床等级相关.
- TRIM32 Knockdown 抑制OSCC细胞的增殖,迁移,入侵,以及体内瘤的生长和转移.
- TRIM32直接结合并促进FBP2的降解,增强OSCC细胞中的糖解.
- FBP2沉默部分扭转了TRIM32敲击的瘤抑制作用.
结论:
- 通过FBP2降解,TRIM32通过调节糖解通过FBP2降解来促进OSCC的进展和转移.
- TRIM32是OSCC治疗的潜在治疗点,特别是考虑到OSCC与糖解增加的关联.
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K

